Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort Add-on to Tiotropium in Severe COPD (SECURE 1)
NCT01397890Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2011
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 4 trial of budesonide + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jul 2011; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01397890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397890.